- Tytuł:
- Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
- Autorzy:
- Źródło:
- In The Lancet Oncology October 2022 23(10):1308-1320
Czasopismo naukowe